Informing the Renovations to the ICH E6 GCP Guideline for GCP Executive Summary
Related: Informing ICH E6 Renovation
ICH E6 Guideline for Good Clinical Practice – Update on Progress
MAY 18, 2021 TO MAY 19, 2021
CTTI Project: Informing the Update of ICH E6
On behalf of the International Council for Harmonisation (ICH), the ICH E6 Good Clinical Practice (GCP) Expert Working Group (EWG) held a free public web conference to provide an update on the progress to revise this important and impactful guideline. This web conference was convened by the Clinical Trials Transformation Initiative (CTTI).
The EWG held two similar meetings on Tuesday, May 18, 2021 (8-11 a.m. EDT) and Wednesday, May 19, 2021 (6-9 pm JST) to reach a broad global audience across time zones. As you will note on the agenda, the same topics were presented each day with speakers from different regions to represent the global effort. All information and presentations was provided in English.
Recorded presentations of the public web conferences are available above.
Meeting Materials:
Video: ICH Guideline Development Process
Presentations:
Session 1 – General Introduction
- Session 1A: Welcome, opening remarks
- Session 1B: ICH Guideline Development Process and the Initial Approach to ICH E6(R3)
Session 2 – E6(R3) GCP Expert Working Group (EWG) Vision & Engagement
- Session 2A: Vision and Goals for the Work to Update ICH E6(R3) GCP Guideline
- Session 2B: Lessons Learned from Public Input & Stakeholder Feedback
Session 3 – Principles & Stakeholder Reflections
Full Web Conference Slide Deck
Additional Meeting Details:
ICH E6 GCP is the international ethical, scientific, and quality standard for the conduct of clinical trials for the development of new drugs and biologics involving human participants that are intended to support regulatory applications. Due to the wide impact of this important guideline, the ICH Management Committee is taking this unique step to provide a status update on the revisions to the guideline.
In this web conference, members of the ICH E6 EWG discussed the work-in-progress to develop principles and annexes for ICH E6 GCP (third version or E6(R3)) that are intended to be responsive across clinical trial types and settings and to remain relevant as technology and methodologies advance. The draft, work-in-progress principles that were made public by the ICH on April 19, 2021, are designed to be flexible and applicable to a broad range of clinical trials. View the principles on the ICH website. The EWG is not taking public comments on the principles at this stage. However, once the ICH E6 guideline achieves step 3 of the ICH guideline development process, the EWG will invite and consider public input.
The EWG also discussed its plans and approaches to update the guideline in general and its engagement efforts with a variety of stakeholders that greatly enriched the discussions of the EWG. As part of these continued efforts to engage with stakeholders, the web conference included presentations from stakeholders on their vision and aspiration for clinical trial design and conduct that are responsive to the needs of the community.
View the full conference agenda here. For additional information on the ICH E6 revision efforts, please see the Reflection Paper on Renovation of Good Clinical Practice and the Concept Paper. For further information on the engagement approach, please see the published outline of the ICH E6 engagement proposal. Other materials, including the current guideline, "ICH E6(R2): Guideline for Good Clinical Practice," the business plan, work plan, an expert list, and reports of prior public engagements are available on the ICH website: https://www.ich.org/page/efficacy-guidelines.
The views and opinions expressed in this presentation are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.
Stakeholder Engagement on ICH E6 Guideline for Good Clinical Practice
JUNE 04, 2020 TO JUNE 05, 2020
CTTI Project: Informing ICH E6 Renovation
Meeting Overview:
The U.S. Food and Drug Administration, in collaboration with the Clinical Trials Transformation Initiative, is organizing a free two-day Pan-American-focused public web conference on Thursday, June 4, and Friday, June 5, from 10:00 a.m. - 1:00 p.m. EDT, to learn more about stakeholder experiences with the International Council for Harmonisation (ICH) Good Clinical Practice guideline (ICH E6).
This stakeholder engagement web conference will inform the discussions of the ICH Expert Working Group (EWG), which is tasked with updating the guideline and making it more responsive to advances in clinical trial design and conduct. Members of the EWG will provide an overview of the ongoing work to update the guideline and will then hear from multiple stakeholders on their experiences with ICH E6(R2).
The registration process gives registrants an opportunity to submit questions. We will address themes from questions submitted before Tuesday, May 26, during a session on Friday, June 5. Please note the following regarding submissions:
- Submissions must be in English.
- Anyone can submit questions or comments.
Time slots for stakeholders to provide oral comments during the second day of the web conference are now filled. Please consider submitting questions when registering or sending written comments to cttievents@dm.duke.edu (External Link Disclaimer).
For additional information on the ICH E6 revision efforts, please refer to the following materials:
- ICH E6 main page (www.ich.org)
- ICH E6(R3) Concept Paper
- Summary of the ICH E6 engagement proposal
- CTTI's ICH E6 Renovation Work
Meeting details are available on FDA’s website.
Meeting Materials:
Day 1
Session I: Introduction/ICH Process & Updating ICH E6 GCP Guidelines
Session II: CTTI ICH E6 Survey and Stakeholder Input
Session III: Perspectives from EWG Members
Session IV: Perspectives from Clinical Investigators
Session V: Perspectives from Patient Organizations
Day 2
Session I: Stakeholders Perspectives
Session II: Moderated Discussion of Themes from Stakeholders
Session III: Stakeholder Comments
The views and opinions expressed in this presentation are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.
Findings & Reflections from CTTI’s ICH E6 Renovation Work
CTTI Project: Informing ICH E6 Renovation
Webinar Presenters:
- Amy Corneli (Clinical Trials Transformation Initiative)
- Pamela Gonzalez (Department of Veterans Affairs)
- Dagmar Gortz (Johnson & Johnson/Janssen)
- Fergus Sweeney (European Medicines Agency)
- Pamela Tenaerts (Clinical Trials Transformation Initiative)
- Celia Witten (Food and Drug Administration/CBER)